Alfa Laval Hopes New Center will Help Pharma Innovation

Swedish industrial manufacturer Alfa Laval has opened its new Innovation Centre in Flemingsberg, Sweden, a move that signals a reinforced focus on creating sustainable solutions for the healthcare and biopharma industries.

The company, which has a 140-year history, inaugurated the new facility at an event for customers, partners and industry leaders, showcasing its latest technologies.

Tom Erixon, Alfa Laval’s CEO and President, and Sweden’s Minister for EU Affairs, Jessica Rosencrantz, were present to officially open the centre.

This investment not only strengthens Alfa Laval’s Swedish roots, located near its 19th-century origins, but also establishes Flemingsberg as its global hub for separator development, with a clear ambition for the pharmaceutical sector.

No Byline Policy

Editorial Guidelines

Corrections Policy

Source